Here are five quick facts about the findings:
1. Ben Franklin Technology Partners approved $1.6 million funding for nine start-ups recent. OrthogenRX will receive $575,000 in funding.
2. OrthogenRx is a product development company that commercializes orthopedic devices and obtains exclusive licenses for products outside the United States, and seeks FDA approval for products.
3. If their Class III medical device approval goes through, they’ll be the first to achieve the approval using their company’s method.
4. Ben Franklin previously awarded $175,000 to OrthogenRx in 2013. That funding went toward filing their first FDA application.
5. OrthogenRx expects approvals in 2014 and sales in 2015.
More articles on orthopedic devices:
20 spine devices receive FDA clearance in November
Cardinal Health acquires Emerge Medical
Bone Biologics names George Oram to board of directors
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
